Mr. Dahl is currently a private investor, focusing on the healthcare industry. Previously, he was the co-founder and Chief Operating Officer of Arrowhawk Capital Partners, an investment company. He also served as the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. From April 1999 until June 2006, Mr. Dahl served as the head of Global Healthcare for the Carlyle Group, a leading private equity firm, where he was responsible for the firm's investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is also a director of several private healthcare companies.
Mr. Dahl received a B.A. from Middlebury College and an M.B.A. from the Harvard Graduate School of Business Administration, where he was a Baker Scholar and recipient of a Loeb Rhodes fellowship.
Let's spread the word about Immunotherapy! Click to share this page with your community.